Ptc Therapeutics Inc (PTCT) returns
Ptc Therapeutics returns over 10 years
$1,000 invested in Ptc Therapeutics ten years ago was worth $9,385 at the close on October 30, 2026, with dividends reinvested: an average return of 25.1% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -7.4% | — | $925.75 | -0.9% |
| 3 months | -20.6% | — | $794.09 | +2.1% |
| Year to date | -21.1% | — | $789.49 | +11.7% |
| 1 year | -12.0% | — | $880.49 | +12.4% |
| 3 years | +220.0% | +47.4% | $3,200 | +88.5% |
| 5 years | +58.1% | +9.6% | $1,581 | +76.0% |
| 10 years | +838.5% | +25.1% | $9,385 | +316.6% |
Ptc Therapeutics return by calendar year
| Year | PTCT | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -21.1% | +11.7% | -32.7% |
| 2025 | +68.3% | +17.7% | +50.6% |
| 2024 | +63.8% | +24.9% | +38.9% |
| 2023 | -27.8% | +26.2% | -54.0% |
| 2022 | -4.2% | -18.2% | +14.0% |
| 2021 | -34.7% | +28.7% | -63.5% |
| 2020 | +27.1% | +18.4% | +8.7% |
| 2019 | +39.9% | +31.2% | +8.7% |
| 2018 | +105.8% | -4.6% | +110.3% |
| 2017 | +52.9% | +21.7% | +31.2% |
| 2016 | -66.3% | +12.0% | -78.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: PTCT financials
No forecast, no recommendation. This page describes Ptc Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.